title: Management of progressive myopathic blepharoptosis with daily application of octyl-2-cyanoacrylate liquid bandage.
abstract: OBJECTIVE
  To describe the results of a conservative and reversible technique for the treatment of progressive myopathic blepharoptosis in cases when surgery is not indicated, using octyl-2-cyanoacrylate liquid bandage.
  
  
  METHODS
  Ten consecutive patients with progressive myopathic blepharoptosis were studied. Octyl-2-cyanoacrylate liquid bandage was applied to the upper eyelid to create a deeper eyelid crease. Margin reflex distance, photographs, and visual fields were obtained prior to and after treatment.
  
  
  RESULTS
  All patients described a better appearance after application of the product, and none had an allergic response. All cases had an increase in the margin reflex distance and improvement in visual fields.
  
  
  CONCLUSIONS
  Octyl-2-cyanoacrylate liquid bandage is an alternative method that is simple, safe, and effective in the management of severe blepharoptosis. Moreover, it can be used in patients without systemic conditions or those who are unwilling to undergo a surgical procedure.
authors.affiliation: Department of Ophthalmology, Santa Casa de São Paulo, SP, Brazil. tammyht32@yahoo.com.br
authors.forename: Tammy H
authors.initials: TH
authors.lastname: Osaki
authors.forename: Midori H
authors.initials: MH
authors.lastname: Osaki
authors.forename: Rubens
authors.initials: R
authors.lastname: Belfort
authors.forename: Teissy
authors.initials: T
authors.lastname: Osaki
authors.forename: Ana Estela
authors.initials: AE
authors.lastname: Sant'anna
authors.forename: Daniel K
authors.initials: DK
authors.lastname: Haraguchi
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D001458:Bandages; D001763:Blepharoptosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D002648:Child; D003487:Cyanoacrylates / Q000008:administration & dosage*; D018450:Disease Progression; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000150:complications* / Q000503:physiopathology; D013997:Time Factors; D014014:Tissue Adhesives / Q000008:administration & dosage*; D016896:Treatment Outcome; D014794:Visual Fields; D055815:Young Adult
chemical_list: D003487:Cyanoacrylates; D014014:Tissue Adhesives; C100832:octyl 2-cyanoacrylate